Ultra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights
Nutrients · 29.10.2026 · 18 (21) · 3585
DOI: 10.3390/nu18213585 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 29.10.2026. Verfasst von Melvin Bernardino und 2 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Liver Disease Unit, Fondazione Italiana Fegato, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: Fatty Liver, Fast Foods, Diet, Metabolic Diseases. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Ultra-processed food (UPF) consumption has been associated with metabolic dysfunction-associated steatotic liver disease (MASLD), but differences in exposure definitions and liver outcomes complicate interpretation. This umbrella review synthesized existing evidence, appraised review methodology, examined primary-publication overlap, and explored proposed biological mechanisms.
Methods
PubMed, Scopus, and Web of Science were searched from inception to May 2026 for systematic reviews and meta-analyses examining UPF consumption and MASLD-related outcomes in adults. The review methodology was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2). Primary publications were mapped across reviews, distinguishing total NOVA-defined UPF intake from selected-food and dietary-pattern proxies. Publication overlap was quantified using the corrected covered area (CCA). Findings were synthesized narratively.
Results
Five systematic reviews were included, with AMSTAR 2 confidence classifications of moderate for one, low for one, and critically low for three. Mapping identified 18 distinct primary publications: 11 assessing total NOVA-defined UPF intake and seven assessing proxy exposures. Higher UPF consumption was generally associated with less favorable liver outcomes, with prospective findings proving more consistent than cross-sectional findings. Publication overlap was very high (overall CCA: 34.72%), limiting the independence of review findings. Other limitations included retrospective NOVA classification, heterogeneous liver-outcome ascertainment, and residual confounding. Proposed biological pathways included excess energy intake, visceral adiposity, insulin resistance, hepatic lipogenesis, and altered gut–liver signaling; their contribution to the observed associations remains unconfirmed.
Conclusions
Existing evidence suggests an association between higher UPF consumption and adverse liver outcomes relevant to MASLD but does not establish causality or a harmful intake threshold. Future research should prioritize repeated dietary assessments, standardized MASLD ascertainment, and interventions evaluating the replacement of UPFs with minimally processed foods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Metabolic Liver Disease Unit, Fondazione Italiana Fegato, 34149 Trieste, Italy.
- Department of Life Science, University of Trieste, 34100 Trieste, Italy.
- Department of Science and Technology, Philippine Council for Health Research and Development, Taguig 1631, Philippines.
ORCID-Profile: Melvin Bernardino, Claudio Tiribelli, Natalia Rosso
Zitieren
APA
Bernardino, M., Tiribelli, C., & Rosso, N. (2026). Ultra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights. Nutrients, 18(21), 3585. https://doi.org/10.3390/nu18213585
Vancouver
Bernardino M, Tiribelli C, Rosso N. Ultra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights. Nutrients. 2026;18(21):3585. doi:10.3390/nu18213585
BibTeX
@article{Bernardino2026,
author = {Bernardino, Melvin and Tiribelli, Claudio and Rosso, Natalia},
title = {Ultra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {21},
pages = {3585},
doi = {10.3390/nu18213585}
}
EUVIMED